[Research Report] The blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028.
Blood transfusion diagnostics are tests performed on blood before they are transfused to patients. A blood transfusion is a common procedure in which the donated blood or its components are transfused into the patient’s body through an intravenous route of administration. Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection.
The report offers insights and in-depth analysis of the global blood transfusion diagnostics market, emphasizing various parameters, including market trends, technological advancements, market dynamics, and competitive landscape analysis of global leading market players. It also includes the impact of the COVID-19 pandemic on the market across all regions. The COVID-19 pandemic negatively impacted the global blood transfusion diagnostics market growth. It showcased a huge decline in revenue due to stringent restrictions imposed by the government resulting in decreasing number of surgical procedures performed. These services are mainly used in surgeries with high blood loss, such as orthopedic and cardiac surgeries. Due to decreasing number of surgeries performed, the demand for blood transfusion has reduced. For Instance: According to the data published by American Medical Association, it was estimated that there was a 48% reduction in total surgical procedures performed in the US due to the COVID-19 pandemic. However, after the pandemic restrictions normalized, the volume of surgical procedures returned to normal levels.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Transfusion Diagnostics Market: Strategic Insights
Market Size Value in US$ 4,096.93 Million in 2021 Market Size Value by US$ 6,483.75 Million by 2028 Growth rate CAGR of 6.9% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Transfusion Diagnostics Market: Strategic Insights
Market Size Value in | US$ 4,096.93 Million in 2021 |
Market Size Value by | US$ 6,483.75 Million by 2028 |
Growth rate | CAGR of 6.9% from 2022 to 2028 |
Forecast Period | 2022-2028 |
Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystGeography-Based Insights
By geography, the global blood transfusion diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Market Insights
Need for Blood Transfusion due to Rise in Organ Transplants Surgeries
Organ transplant is a surgical procedure performed in case of organ failure. Usually, organ transplant surgeries are conducted for the heart, liver, kidney, and various other organs due to the rising cases of chronic diseases, such as chronic kidney disease (CKD), polycystic kidney disease, cystic fibrosis, and congenital heart disease, which require transplants. These procedures generally take hours, and there is a lot of blood loss and requires the need for blood transfusion. For instance, according to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, according to World Transplant Registry data, Spain accounted for 20% of all organ donations in Europe in 2019 and 6% worldwide. Australia's organ donor rate has improved recently, rising to 21.8 donors per million population in 2019.
Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the "Donation Physicians" figure—intensive care doctors responsible for organ donation. According to the World Transplant Registry, China had 5,818 donors in 2019, or 4.1 per million population, and India had 715 donors, or 0.5 per million population in 2019. On the other hand, Russia had a slightly higher rate of 5.1 donors per million people. The public-private partnership, in collaboration with transplant coordinators, has significantly contributed to the improvement of organ transplants requiring constant blood transfusion. Both developing and developed countries have seen an increase in organ transplant surgeries. For example, developing countries, such as India and Singapore, are emerging as medical tourism destinations in Asia Pacific. Countries are progressing in terms of providing better and advanced medical treatments. The rising need for organ transplants is among the key factors driving the demand for blood transfusion diagnostics worldwide.
Product-Based Insights
Based on product, the global blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. In 2021, the instruments & kits segment accounted for a larger market share. The same segment is expected to register a higher CAGR in the market from 2022 to 2028.
Application-Based Insights
Based on application, the global blood transfusion diagnostics market is bifurcated into disease screening and blood grouping. The disease screening segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period.
Blood Transfusion Diagnostics Market Report Scope
End User-Based Insights
Based on end user, the global blood transfusion diagnostics market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies. The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the market from 2022 to 2028.
The global blood transfusion diagnostics market players take up organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing demand. The key players in the market are Grifols, S.A.; F. Hoffmann-La Roche Ltd; Immucor, Inc.; Bio-Rad Laboratories, Inc.; Abbott; Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; DiaSorin S.p.A.; Quotient Limited; and BAG Diagnostics GmbH.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global blood transfusion diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for blood transfusion diagnostics market. The growth of the market in North America is expected due to the factors such as increasing surgical procedures for chronic health conditions, rising collaborative agreements between key players, and growing progress in the health system for blood transfusion diagnostics. However, the improvement in blood transfusion management, increasing prevalence of sepsis and thalassemia, and the introduction of advanced molecular platforms are the key factor responsible for the Asia-Pacific regional growth for blood transfusion diagnostics accounting fastest growth of the region during the coming years.
Grifols, S.A.; F. Hoffmann-La Roche Ltd; DiaSorin S.p.A.; BAG Diagnostics GmbH; Abbott; Bio-Rad Laboratories, Inc.; Immucor, Inc.; Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; and Quotient Limited are among the leading companies operating in the blood transfusion diagnostics market.
The blood banks segment dominated the global blood transfusion diagnostics market and accounted for the largest market share of 40.23% in 2021.
Based on application, disease screening segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Based on products, instruments and kits segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Blood transfusion diagnostics refers to tests performed on blood and blood components before they are transfused to patients. A blood transfusion is a common procedure in which donated blood or blood components are transfused into the patient's body through an intravenous line (IV). Each unit of blood must undergo blood typing, which refers to the identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection. Blood screening before transfusion is performed through instruments, kits, and reagents to identify various diseases, such as HIV, hepatitis B, hepatitis C, Zika, and different viruses and infections.
Rapid increase in chronic diseases and increasing need for blood transfusion due to rise in organ transplants surgeries are the most significant factors responsible for the overall market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Blood Transfusion Diagnostics Market – By Product
1.3.2 Global Blood Transfusion Diagnostics Market – By Application
1.3.3 Global Blood Transfusion Diagnostics Market – By End User
1.3.4 Global Blood Transfusion Diagnostics Market – By Geography
2. Blood Transfusion Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Blood Transfusion Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion
5. Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Increase in Chronic Diseases
5.1.2 Need For Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
5.2.1 Problems associated with Blood Transfusion Services
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.3.2 Growing Initiatives by Governments
5.4 Future Trends
5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis
6. Blood Transfusion Diagnostics Market– Global Analysis
6.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
6.1.1 Global Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
6.1.2 Global Blood Transfusion Diagnostics Market – Market Potential Analysis, By Region
6.2 Market Share Analysis of Key Players in Blood Transfusion Diagnostics Market
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Performance of Key Players
6.2.3.1 Grifols S.A.
6.2.3.2 F. Hoffmann-La Roche Ltd
7. Blood Transfusion Diagnostics Market Analysis and Forecasts To 2028 – By Product
7.1 Overview
7.2 Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
7.3.1 Overview
7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8. Blood Transfusion Diagnostics Market Analysis – By Application
8.1 Overview
8.2 Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
8.3.1 Overview
8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
8.4.1 Overview
8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9. Blood Transfusion Diagnostics Market Analysis – By End User
9.1 Overview
9.2 Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
9.3.1 Overview
9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
9.6.1 Overview
9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
10. Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Blood Transfusion Diagnostics Market
10.1.1 Overview
10.1.2 North America: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.4 North America: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.5 North America: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.6 North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.6.1.3 US: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.6.1.4 US: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.6.2 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.6.2.3 Canada: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.6.2.4 Canada: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.6.3 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.6.3.3 Mexico: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.6.3.4 Mexico: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2 Europe: Blood Transfusion Diagnostics Market
10.2.1 Overview
10.2.2 Europe: Blood Transfusion Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.4 Europe: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.5 Europe: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2.6 Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.6.1.3 Germany: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.6.1.4 Germany: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2.6.2 UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 UK: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.6.2.3 UK: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.6.2.4 UK: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2.6.3 France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 France: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.6.3.3 France: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.6.3.4 France: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2.6.4 Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Italy: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.6.4.3 Italy: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.6.4.4 Italy: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2.6.5 Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Spain: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.6.5.3 Spain: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.6.5.4 Spain: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.2.6.6 Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.2.6.6.3 Rest of Europe: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.2.6.6.4 Rest of Europe: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.3 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.3 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.4 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.5 Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6 Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.6.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.6.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.6.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.6.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.6.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.6 Rest of Asia Pacific: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.4 South and Central America Blood Transfusion Diagnostics Market
10.4.1 Overview
10.4.2 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.4.4 South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.4.5 South and Central America: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.6 South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.4.6.1 Brazil: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Overview
10.4.6.1.2 Brazil Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.4.6.1.4 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.1.5 Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.4.6.2 Argentina: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 Overview
10.4.6.2.2 Argentina Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.4.6.2.4 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.2.5 Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.4.6.3 Rest of the South and Central America: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 Overview
10.4.6.3.2 Rest of the South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.4.6.3.4 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.3.5 Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5 Middle East & Africa Blood Transfusion Diagnostics Market
10.5.1 Overview
10.5.2 Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.5.3 Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.5.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.5 Middle East & Africa: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6 Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.5.6.1 South Africa: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Overview
10.5.6.1.2 South Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 South Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.5.6.1.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.1.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5.6.2 Saudi Arabia: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Overview
10.5.6.2.2 Saudi Arabia Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.5.6.2.4 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.2.5 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5.6.3 UAE: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Overview
10.5.6.3.2 UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.5.6.3.4 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.3.5 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5.6.4 Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.4.1 Overview
10.5.6.4.2 Rest of the Middle East and Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.3 Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.5.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)
11. Impact of COVID-19 Pandemic on Blood Transfusion Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Blood Transfusion Diagnostics Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Blood Transfusion Diagnostics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Grifols, S.A.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Immucor, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bio-Rad Laboratories, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DiaSorin S.p.A.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Quotient Limited
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BAG Diagnostics GmbH
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. US: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. France: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23. France: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).
Table 35. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 36. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 37. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 38. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 39. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 40. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 41. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 42. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 43. India: National Estimation of Blood Requirement in India (2018)
Table 44. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 45. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 46. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 47. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 48. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 49. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 50. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 51. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 52. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 53. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 54. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 55. Rest of Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 56. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 57. South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 58. South and Central America: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 59. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 60. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 63. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 64. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 65. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 66. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 67. Rest of South & Central America: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 68. Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 69. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 70. Middle East & Africa: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 71. South Africa Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 72. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 73. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 74. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 75. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 76. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 77. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 78. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 79. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 80. Rest of Middle East & Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 81. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 82. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 83. Recent Inorganic Growth Strategies in the Blood Transfusion Diagnostics Market
Table 84. Recent Organic Growth Strategies in the Blood Transfusion Diagnostics Market
Table 85. Glossary of Terms
LIST OF FIGURES
Figure 1. Blood Transfusion Diagnostics Market Segmentation
Figure 2. Blood Transfusion Diagnostics Market – By Geography
Figure 3. Blood Transfusion Diagnostics Market Overview
Figure 4. Instruments and Kits Segment Held Largest Share by Type of Blood Transfusion Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Blood Transfusion Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Blood Transfusion Diagnostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Blood Transfusion Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis
Figure 16. Global Blood Transfusion Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Blood Transfusion Diagnostics Market– Revenue Forecast And Analysis – 2021 - 2028
Figure 18. Global Blood Transfusion Diagnostics Market – Market Potential Analysis, By Region
Figure 19. Market Share Analysis of Key Players in Global Blood Transfusion Diagnostics Market
Figure 20. Global Blood Transfusion Diagnostics Market – Comparative Company Analysis
Figure 21. Global Blood Transfusion Diagnostics Market – Growth Strategy Analysis
Figure 22. Market positioning of Key Players in Blood Transfusion Diagnostics Market
Figure 23. Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
Figure 24. Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
Figure 27. Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 30. Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 33. Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America: Blood Transfusion Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 35. North America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 36. North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 37. US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Europe: Blood Transfusion Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 41. Europe Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 42. Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 43. Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Asia Pacific Blood Transfusion Diagnostics Market Overview, by Country (2021)
Figure 50. Asia Pacific: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. Asia Pacific: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 52. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 54. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. Rest of Asia Pacific: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. South and Central America Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 59. South and Central America Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. South and Central America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 61. Brazil: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Argentina: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of the South and Central America: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa Blood Transfusion Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 65. Middle East & Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East & Africa: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 67. South Africa: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. Rest of the Middle East and Africa: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 71. Impact of COVID-19 Pandemic in North America Country Markets
Figure 72. Impact of COVID-19 Pandemic on European Country Markets
Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 74. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 75. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 76. Growth Strategies in the Blood Transfusion Diagnostics Market
The List of Companies - Blood Transfusion Diagnostics Market
- Grifols, S.A.
- F. Hoffmann-La Roche Ltd
- Immucor, Inc.
- Bio-Rad Laboratories Inc.
- Abbott
- Thermo Fisher Scientific Inc.
- Ortho Clinical Diagnostics
- DiaSorin S.p.A.
- Quotient Limited
- BAG Diagnostics GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Blood Transfusion Diagnostics Market
Jul 2022
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Jul 2022
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Jul 2022
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Jul 2022
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Jul 2022
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Jul 2022
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Jul 2022
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)